Curran Simpson, SVP, Technical Operations at REGENXBIO Inc. (RGNX), sold 61,764 shares at $63.64 ($3.9M) on 2018-11-16, disclosed to the SEC on 2018-11-20.
Open-market sale of $3.9M RGNX by SVP, Technical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.91 | 4,000 | $248K | 6.3% |
| 2 | $62.79 | 6,883 | $432K | 11.0% |
| 3 | $62.79 | 6,883 | $432K | 11.0% |
| 4 | $63.64 | 6,505 | $414K | 10.5% |
| 5 | $63.64 | 6,505 | $414K | 10.5% |
| 6 | $64.71 | 15,494 |
| $1.0M |
| 25.4% |
| 7 | $64.71 | 15,494 | $1.0M | 25.4% |
| Total | $63.88 avg | 61,764 | $3.9M | 100% |
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |